Shrivardhan Bio Tech Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 11-07-2024
- Paid Up Capital ₹ 1.50 Cr
as on 11-07-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 57.25 Cr
as on 11-07-2024
- Revenue -41.57%
(FY 2021)
- Profit 9.15%
(FY 2021)
- Ebitda -1074.84%
(FY 2021)
- Net Worth -21.60%
(FY 2021)
- Total Assets -8.05%
(FY 2021)
About Shrivardhan Bio Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company has closed loans amounting to ₹57.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Nirmala Patil, Sandhya Patil, Lata Patil, and Three other members serve as directors at the Company.
- CIN/LLPIN
U01122PN2007PTC129902
- Company No.
129902
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shrivardhan Bio Tech?
Board Members(6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nirmala Patil | Director | 03-Apr-2007 | Current |
Sandhya Patil | Director | 15-May-2008 | Current |
Lata Patil | Director | 03-Apr-2007 | Current |
Ganpatrao Patil | Director | 03-Apr-2007 | Current |
Sampada Desai | Director | 03-Apr-2007 | Current |
Asmita Patil | Director | 15-May-2008 | Current |
Financial Performance and Corporate Structure Insights of Shrivardhan Bio Tech.
Shrivardhan Bio Tech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 41.57% decrease. The company also saw a slight improvement in profitability, with a 9.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Shrivardhan Bio Tech?
In 2021, Shrivardhan Bio Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Urjankur Shree Datta Power Company LimitedActive 16 years 9 months
Ganpatrao Patil is a mutual person
- Centre For International Trade In Agriculture And Agro Based IndustriesActive 20 years 8 months
Ganpatrao Patil is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Rbl Bank Limited Creation Date: 02 Jan 2015 | ₹16.27 Cr | Satisfied |
Rbl Bank Limited Creation Date: 30 Dec 2014 | ₹2.15 Cr | Satisfied |
Rbl Bank Limited Creation Date: 30 Dec 2014 | ₹14.12 Cr | Satisfied |
How Many Employees Work at Shrivardhan Bio Tech?
Unlock and access historical data on people associated with Shrivardhan Bio Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shrivardhan Bio Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrivardhan Bio Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.